> Caution should be used with antithrombotic medicinal products, antiplatelet medicinal products, and medicinal products that may lower platelet count, for example acetylsalicylic  acid, CLOPIDOGREL, WARFARIN, HEPARIN, low-molecular weight heparins, FACTOR XA INHIBITORS such as RIVAROXABAN and APIXABAN, and thrombin inhibitors such as DABIGATRAN (see sections 4.2 and 4.4).
> Caution should be exercised with concomitant use of nephrotoxic medicinal products and other medicines that may impair renal function, such as SULFONAMIDES, ALDOSTERONE ANTAGONISTS, ANILIDES, NATURAL OPIUM ALKALOIDS and OTHER OPIOIDS (see section 4.4).  A systematic assessment of co -administration of INOTERSEN and potentially nephrotoxic medicinal products has not been conducted. 
